Only one company (besides existing trillion-dollar AI companies) will reach trillion-dollar valuation in the next 3-5 years.
“I mean, there's one I can think of that could maybe get there, but not not multiple. So yeah. What's the one”
→ Read the source episode
Our resolution criterion
disputableCount of companies reaching $1 trillion market capitalization between 2026 and 2031, excluding Anthropic, OpenAI, and SpaceX.
More from No Priors: Artificial Intelligence | Technology | Startups
Renee Haas predicts that within 5+ years, chip design from idea to GDS2 file will be possible for certain designs, likely using AI tooling.
Max Hodak predicts that Cyens' in-house gene therapy will enter human trials within approximately one year
Renee Haas predicts that semiconductor supply chain constraints will persist for 3-5 years at minimum.
Max Hodak predicts that the next version of Prima will enter human trials within approximately one year and expand addressable patient population to millions
Max Hodak predicts that Cyens will make first commercial sales of Prima in Europe within weeks of July 2026
Brian Armstrong predicts New Limit will launch its first phase one clinical trial for epigenetic reprogramming in the next year (2027).
Summaries are ours; the quote is a verbatim transcript excerpt. Our resolution criteria are editorial and disputable. How this works.